Osteosarcoma (OS) is a malignant bone tumour that commonly occurs in paediatric and adolescent patients. Currently, effective therapy for OS remains elusive due to poor patient survival rates. In this study, we observed significantly elevated expressions of circTUBA1C in OS tumours and cells. Silencing circTUBA1C effectively suppressed proliferation and glucose metabolism, and promoted apoptosis of OS cells. Furthermore, we discovered that miR-143-3p played a reverse role to circTUBA1C in OS cells. Bioinformatics analysis, RNA pull-down assay, and luciferase assay demonstrated that circTUBA1C acted as a sponge for miR-143-3p, blocking its expression in OS cells. Finally, rescue experiments showed that inhibition of miR-143-3p in circTUBA1C-silenced OS cells significantly overrode the low-circTUBA1C-mediated miR-143-3p upregulation and OS cell progression in vitro and in vivo . Our results demonstrate the critical roles and molecular targets of circTUBA1C in modulating OS progression, suggesting that circTUBA1C inhibition could serve as a new therapeutic strategy for treating OS.
骨肉瘤(Osteosarcoma,OS)是一种常见于儿童和青少年患者的恶性骨肿瘤。目前,由于患者存活率较低,有效治疗骨肉瘤的方法仍未出现。在这项研究中,我们观察到OS肿瘤和细胞中circTUBA1C的表达明显升高。沉默 circTUBA1C 能有效抑制 OS 细胞的增殖和糖代谢,并促进其凋亡。此外,我们还发现,miR-143-3p 在 OS 细胞中与 circTUBA1C 起着反向作用。生物信息学分析、RNA牵引实验和荧光素酶实验表明,circTUBA1C是miR-143-3p的海绵,阻断了miR-143-3p在OS细胞中的表达。最后,拯救实验表明,在体外和体内,抑制被 circTUBA1C 沉默的 OS 细胞中的 miR-143-3p 能显著克服低 circTUBA1C 介导的 miR-143-3p 上调和 OS 细胞进展。我们的研究结果证明了circTUBA1C在调节OS进展中的关键作用和分子靶点,表明抑制circTUBA1C可作为治疗OS的一种新策略。
{"title":"CircRNA TUBA1C promotes proliferation and glucose metabolism, and blocks apoptosis of osteosarcoma cells through sponging miR-143-3p.","authors":"Yi-Bing Liu, Wen-Hao Dai, Jun-Jie Chang, Kang Wei","doi":"10.5114/pjp.2024.143231","DOIUrl":"https://doi.org/10.5114/pjp.2024.143231","url":null,"abstract":"<p><p>Osteosarcoma (OS) is a malignant bone tumour that commonly occurs in paediatric and adolescent patients. Currently, effective therapy for OS remains elusive due to poor patient survival rates. In this study, we observed significantly elevated expressions of circTUBA1C in OS tumours and cells. Silencing circTUBA1C effectively suppressed proliferation and glucose metabolism, and promoted apoptosis of OS cells. Furthermore, we discovered that miR-143-3p played a reverse role to circTUBA1C in OS cells. Bioinformatics analysis, RNA pull-down assay, and luciferase assay demonstrated that circTUBA1C acted as a sponge for miR-143-3p, blocking its expression in OS cells. Finally, rescue experiments showed that inhibition of miR-143-3p in circTUBA1C-silenced OS cells significantly overrode the low-circTUBA1C-mediated miR-143-3p upregulation and OS cell progression in vitro and in vivo . Our results demonstrate the critical roles and molecular targets of circTUBA1C in modulating OS progression, suggesting that circTUBA1C inhibition could serve as a new therapeutic strategy for treating OS.</p>","PeriodicalId":49692,"journal":{"name":"Polish Journal of Pathology","volume":"75 3","pages":"215-227"},"PeriodicalIF":0.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142511745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The role of cancer stem cells (CSC) in oral cancer is widely accepted. Yet, the existence of CSC in dysplastic tissue and the molecular pathways of progression from dysplasia to malignancy remain to be explored. Our retrospective study aimed to analyze the presence of CSC in oral epithelial dysplasia and oral squamous cell carcinoma (OSCC) concerning two epithelial-mesenchymal transition markers: Snail and E-cadherin. Formalin-fixed, paraffin-embedded tissue samples of oral epithelial dysplasia (OED), OSCC, and oral epithelial hyperplasia (OEH) were used. Immunohistochemistry and quantitative RT-qPCR detected the expression of Snail and CD133, whereas CD44 and E-cadherin were evaluated solely immunohistochemically. OSCC cases showed significantly higher CD133 immunoreactivity and inflammation scores and significantly decreased E-cadherin expression compared to OED and OEH groups. Snail mRNA up-regulation was seen in 100% of the OSCC cases followed by 85% for OED cases and 82.5% OEH cases among those that displayed positive mRNA expression by RT-qPCR. The Snail upregulation in all OSCC cases proves that Snail plays a significant role in oral cancer. Our results also suggest that CD133 and E-cadherin may be potential diagnostic markers in oral cancer progression.
{"title":"Epithelial mesenchymal transition and cancer stem cell markers in oral epithelial dysplasia and oral squamous cell carcinoma.","authors":"Burcu Tokozlu, Özlem Özer Yücel, Sibel E Gültekin, Leyla Arslan Bozdağ","doi":"10.5114/pjp.2024.145818","DOIUrl":"https://doi.org/10.5114/pjp.2024.145818","url":null,"abstract":"<p><p>The role of cancer stem cells (CSC) in oral cancer is widely accepted. Yet, the existence of CSC in dysplastic tissue and the molecular pathways of progression from dysplasia to malignancy remain to be explored. Our retrospective study aimed to analyze the presence of CSC in oral epithelial dysplasia and oral squamous cell carcinoma (OSCC) concerning two epithelial-mesenchymal transition markers: Snail and E-cadherin. Formalin-fixed, paraffin-embedded tissue samples of oral epithelial dysplasia (OED), OSCC, and oral epithelial hyperplasia (OEH) were used. Immunohistochemistry and quantitative RT-qPCR detected the expression of Snail and CD133, whereas CD44 and E-cadherin were evaluated solely immunohistochemically. OSCC cases showed significantly higher CD133 immunoreactivity and inflammation scores and significantly decreased E-cadherin expression compared to OED and OEH groups. Snail mRNA up-regulation was seen in 100% of the OSCC cases followed by 85% for OED cases and 82.5% OEH cases among those that displayed positive mRNA expression by RT-qPCR. The Snail upregulation in all OSCC cases proves that Snail plays a significant role in oral cancer. Our results also suggest that CD133 and E-cadherin may be potential diagnostic markers in oral cancer progression.</p>","PeriodicalId":49692,"journal":{"name":"Polish Journal of Pathology","volume":"75 4","pages":"305-314"},"PeriodicalIF":0.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143061320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
There is growing evidence that the KDM5 family of histone demethylases plays a causal role in human cancer. However, few studies have been reported on the KDM5 family in endometrial carcinoma (EC). Moreover, it was found that there was some correlation between the KDM5 family and FOXO1 in EC. The current study was performed to explore the expressions of KDM5A, KDM5B, and FOXO1 in endometrioid adenocarcinoma detected by immunohistochemistry; paracancer endometrium, simple hyperplastic endometrium, and normal endometrium were used as control groups to explore the possible diagnostic value of KDM5A and KDM5B expression in endometrioid adenocarcinoma, with the aim of evaluating the potential of this marker in predicting the prognosis of endometrioid adenocarcinoma.
{"title":"Expression and clinical significance of KDM5A, KDM5B, and FOXO1 in endometrial cancer.","authors":"Yao Gao, Jun Gao","doi":"10.5114/pjp.2024.139610","DOIUrl":"https://doi.org/10.5114/pjp.2024.139610","url":null,"abstract":"<p><p>There is growing evidence that the KDM5 family of histone demethylases plays a causal role in human cancer. However, few studies have been reported on the KDM5 family in endometrial carcinoma (EC). Moreover, it was found that there was some correlation between the KDM5 family and FOXO1 in EC. The current study was performed to explore the expressions of KDM5A, KDM5B, and FOXO1 in endometrioid adenocarcinoma detected by immunohistochemistry; paracancer endometrium, simple hyperplastic endometrium, and normal endometrium were used as control groups to explore the possible diagnostic value of KDM5A and KDM5B expression in endometrioid adenocarcinoma, with the aim of evaluating the potential of this marker in predicting the prognosis of endometrioid adenocarcinoma.</p>","PeriodicalId":49692,"journal":{"name":"Polish Journal of Pathology","volume":"75 2","pages":"83-96"},"PeriodicalIF":0.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142019321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cancer stem cells (CSCs) are cancer cells responsible for cancer initiation, growth, metastasis, recurrence and resistance to treatment. OCT4 and c-MYC are widely accepted as CSC markers. In this study, we examined the immunohistochemical co-expression of c-MYC and OCT4 with Ki-67 in colorectal cancers (CRC) and the relationship between the results and prognostic and therapeutic data. c-MYC, OCT4 and Ki67 immunohistochemical staining was applied to 162 colectomy cases. Nuclear staining was considered for immunohistochemical staining. Survival in the c-MYC H /OCT4 H subtype, which is one of the subtypes based on c-MYC and OCT4 co-expression, was different from the other subtypes and statistically significant. Although these markers are enriched in cancer stem cells, their specificity in identifying them is limited. CSCs become dormant in the cell cycle, which is one of the mechanisms of escape in drug resistance. We hypothesized that including Ki67 immunohistochemical staining in our study would increase the specificity in detecting CSCs. Our results show that the Ki67 L /c-MYC H /OCT4 H subgroup was associated with lower survival and resistance to treatment compared to the other subgroups. This finding may provide insight into cases with a high number of CSCs and guide targeted treatments.
{"title":"Clinicopathological importance of immunohistochemical expression of OCT4, c-MYC and Ki-67 in colorectal cancer.","authors":"Rabia Hursitoglu, Abdulkadir Yasir Bahar, Sezen Koçarslan, Gökmen Aktaş, Neslihan Kurtul, Emine Kılınç","doi":"10.5114/pjp.2024.146463","DOIUrl":"https://doi.org/10.5114/pjp.2024.146463","url":null,"abstract":"<p><p>Cancer stem cells (CSCs) are cancer cells responsible for cancer initiation, growth, metastasis, recurrence and resistance to treatment. OCT4 and c-MYC are widely accepted as CSC markers. In this study, we examined the immunohistochemical co-expression of c-MYC and OCT4 with Ki-67 in colorectal cancers (CRC) and the relationship between the results and prognostic and therapeutic data. c-MYC, OCT4 and Ki67 immunohistochemical staining was applied to 162 colectomy cases. Nuclear staining was considered for immunohistochemical staining. Survival in the c-MYC H /OCT4 H subtype, which is one of the subtypes based on c-MYC and OCT4 co-expression, was different from the other subtypes and statistically significant. Although these markers are enriched in cancer stem cells, their specificity in identifying them is limited. CSCs become dormant in the cell cycle, which is one of the mechanisms of escape in drug resistance. We hypothesized that including Ki67 immunohistochemical staining in our study would increase the specificity in detecting CSCs. Our results show that the Ki67 L /c-MYC H /OCT4 H subgroup was associated with lower survival and resistance to treatment compared to the other subgroups. This finding may provide insight into cases with a high number of CSCs and guide targeted treatments.</p>","PeriodicalId":49692,"journal":{"name":"Polish Journal of Pathology","volume":"75 4","pages":"333-342"},"PeriodicalIF":0.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143030121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Head and neck squamous cell carcinoma (HNSCC) exhibits a poor 5-year survival rate. TNFRSF4 is gaining attention in tumor therapy. The objective of this study was to forecast the expression of TNFRSF4 in HNSCC tissue using analysis of pathological images and investigate its possible molecular mechanisms. Transcriptome, clinical, and pathological data of HNSCC patients from the TCGA database were analyzed. Features were extracted with PyRadiomics for support vector machine model development. The evaluation of model performance was conducted using ROC curve, calibration curve, and decision curve analyses. The correlation between pathomics score (PS), patient prognosis, and immune- related genes was assessed. TNFRSF4 expression was significantly higher in the tumor group and indepen-dently associated with HNSCC prognosis. Features were extracted to build a predictive model for TNFRSF4, which demonstrated strong performance. PS correlated positively with immune-related genes. This research highlights the potential of TNFRSF4 as a prognostic factor and demonstrates the utility of PS in relation to immune-related genes.
{"title":"Predicting TNFRSF4 expression and prognosis in head and neck squamous cell carcinoma tissue: a pathological image analysis approach.","authors":"Weiming Chu, Chen Chu, Zongmei Ding, Wei Guan, Shiyuan Li, Jixin Jiang, Yu Xue, Jianping Qiu, Aijun Guo","doi":"10.5114/pjp.2024.146147","DOIUrl":"https://doi.org/10.5114/pjp.2024.146147","url":null,"abstract":"<p><p>Head and neck squamous cell carcinoma (HNSCC) exhibits a poor 5-year survival rate. TNFRSF4 is gaining attention in tumor therapy. The objective of this study was to forecast the expression of TNFRSF4 in HNSCC tissue using analysis of pathological images and investigate its possible molecular mechanisms. Transcriptome, clinical, and pathological data of HNSCC patients from the TCGA database were analyzed. Features were extracted with PyRadiomics for support vector machine model development. The evaluation of model performance was conducted using ROC curve, calibration curve, and decision curve analyses. The correlation between pathomics score (PS), patient prognosis, and immune- related genes was assessed. TNFRSF4 expression was significantly higher in the tumor group and indepen-dently associated with HNSCC prognosis. Features were extracted to build a predictive model for TNFRSF4, which demonstrated strong performance. PS correlated positively with immune-related genes. This research highlights the potential of TNFRSF4 as a prognostic factor and demonstrates the utility of PS in relation to immune-related genes.</p>","PeriodicalId":49692,"journal":{"name":"Polish Journal of Pathology","volume":"75 4","pages":"287-304"},"PeriodicalIF":0.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143030231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Michał Bielówka, Jakub Kufel, Marcin Rojek, Dominika Kaczyńska, Łukasz Czogalik, Adam Mitręga, Wiktoria Bartnikowska, Dominika Kondoł, Kacper Palkij, Sylwia Mielcarska
This study evaluates the effectiveness of the ChatGPT-3.5 language model in providing correct answers to pathomorphology questions as required by the State Speciality Examination (PES). Artificial intelligence (AI) in medicine is generating increasing interest, but its potential needs thorough evaluation. A set of 119 exam questions by type and subtype were used, which were posed to the ChatGPT-3.5 model. Performance was analysed with regard to the success rate in different question categories and subtypes. ChatGPT-3.5 achieved a performance of 45.38%, which is significantly below the minimum PES pass threshold. The results achieved varied by question type and subtype, with better results in questions requiring "comprehension and critical thinking" than "memory". The analysis shows that, although ChatGPT-3.5 can be a useful teaching tool, its performance in providing correct answers to pathomorphology questions is significantly lower than that of human respondents. This conclusion highlights the need to further improve the AI model, taking into account the specificities of the medical field. Artificial intelligence can be helpful, but it cannot fully replace the experience and knowledge of specialists.
{"title":"An investigative analysis - ChatGPT's capability to excel in the Polish speciality exam in pathology.","authors":"Michał Bielówka, Jakub Kufel, Marcin Rojek, Dominika Kaczyńska, Łukasz Czogalik, Adam Mitręga, Wiktoria Bartnikowska, Dominika Kondoł, Kacper Palkij, Sylwia Mielcarska","doi":"10.5114/pjp.2024.143091","DOIUrl":"https://doi.org/10.5114/pjp.2024.143091","url":null,"abstract":"<p><p>This study evaluates the effectiveness of the ChatGPT-3.5 language model in providing correct answers to pathomorphology questions as required by the State Speciality Examination (PES). Artificial intelligence (AI) in medicine is generating increasing interest, but its potential needs thorough evaluation. A set of 119 exam questions by type and subtype were used, which were posed to the ChatGPT-3.5 model. Performance was analysed with regard to the success rate in different question categories and subtypes. ChatGPT-3.5 achieved a performance of 45.38%, which is significantly below the minimum PES pass threshold. The results achieved varied by question type and subtype, with better results in questions requiring \"comprehension and critical thinking\" than \"memory\". The analysis shows that, although ChatGPT-3.5 can be a useful teaching tool, its performance in providing correct answers to pathomorphology questions is significantly lower than that of human respondents. This conclusion highlights the need to further improve the AI model, taking into account the specificities of the medical field. Artificial intelligence can be helpful, but it cannot fully replace the experience and knowledge of specialists.</p>","PeriodicalId":49692,"journal":{"name":"Polish Journal of Pathology","volume":"75 3","pages":"236-240"},"PeriodicalIF":0.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142511742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yang Yang, Yuezhi Zhang, Yanmei Fu, Shuanglian Li, Xiaolong Yin
Retinoblastoma is the most common primary intraocular malignancy of childhood. The aim of our study was to investigate the role and regulatory mechanism of the long non-coding RNA ANRIL in retinoblastoma. Here, our data demonstrated that ANRIL overexpression inhibited miR-328-3p expression, but promoted expression of autophagy-related proteins (LC3B, ATG5, and BECN1). Then we predicted the binding sites for ANRIL with miR-328-3p, and for miR-328 3p with TSC1/ULK2 3'-UTR, and confirmed the combination of miR-328-3p and ANRIL and TSC1/ULK2 3'-UTR. Importantly, the data showed that ANRIL overexpression promoted TSC1 and ULK2 expression, and inhibited the phosphorylation of mTOR. Finally, our results indicated that ANRIL overexpression facilitated Y79 cell proliferation and cisplatin-induced apoptosis. Our results indicated that ANRIL promoted the proliferation and cisplatin resistance of Y79 cells through activating autophagy by promoting TSC1/ULK2 ex- pression via acting as a miR-328-3p sponge.
{"title":"ANRIL regulates retinoblastoma progression via targeting autophagy by miR-328-3p/TSC1/ULK signaling.","authors":"Yang Yang, Yuezhi Zhang, Yanmei Fu, Shuanglian Li, Xiaolong Yin","doi":"10.5114/pjp.2024.142177","DOIUrl":"https://doi.org/10.5114/pjp.2024.142177","url":null,"abstract":"<p><p>Retinoblastoma is the most common primary intraocular malignancy of childhood. The aim of our study was to investigate the role and regulatory mechanism of the long non-coding RNA ANRIL in retinoblastoma. Here, our data demonstrated that ANRIL overexpression inhibited miR-328-3p expression, but promoted expression of autophagy-related proteins (LC3B, ATG5, and BECN1). Then we predicted the binding sites for ANRIL with miR-328-3p, and for miR-328 3p with TSC1/ULK2 3'-UTR, and confirmed the combination of miR-328-3p and ANRIL and TSC1/ULK2 3'-UTR. Importantly, the data showed that ANRIL overexpression promoted TSC1 and ULK2 expression, and inhibited the phosphorylation of mTOR. Finally, our results indicated that ANRIL overexpression facilitated Y79 cell proliferation and cisplatin-induced apoptosis. Our results indicated that ANRIL promoted the proliferation and cisplatin resistance of Y79 cells through activating autophagy by promoting TSC1/ULK2 ex- pression via acting as a miR-328-3p sponge.</p>","PeriodicalId":49692,"journal":{"name":"Polish Journal of Pathology","volume":"75 3","pages":"228-235"},"PeriodicalIF":0.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142511743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The 5-10% of breast cancers (BC) are hereditary, and BRCA1/2 are causative in 25% of those inherited. It was aimed to examine the BRCA1/2 genotype-BC phenotype relationship. In 170 female patients with BC, BRCA1/2 genes were investigated using Next Generation Sequencing. Demographic and clinicopathological characteristics of the patients and correlations of pedigree analysis with BRCA1/2 mutation status were analysed. BRCA1/2 carriage was found to be 9.4%. When the patients were grouped as ≤ 40 and > 40 according to the age at diagnosis of BC, the tumour grade was higher in the ≤ 40 groups. In the study, BRCA1/2 carriage and tumour grade were higher in patients with triple-negative breast cancers (TNBC). The risk of TNBC was 5.560 times higher in BRCA1/2 carriers than in non-carriers. There is a significant relationship between BRCA1/2 carrier and BC hormone receptor negativity, tumour grade, and BC diagnosis age.
5%-10%的乳腺癌(BC)具有遗传性,其中25%的遗传性乳腺癌是由BRCA1/2引起的。本研究旨在探讨 BRCA1/2 基因型与 BC 表型之间的关系。研究使用新一代测序技术对170名女性乳腺癌患者的BRCA1/2基因进行了检测。分析了患者的人口统计学和临床病理学特征,以及血统分析与 BRCA1/2 基因突变状态的相关性。结果发现,BRCA1/2携带率为9.4%。根据 BC 诊断时的年龄将患者分为≤40 岁和大于 40 岁两组,≤40 岁组的肿瘤分级更高。在该研究中,三阴性乳腺癌(TNBC)患者的BRCA1/2携带率和肿瘤等级更高。BRCA1/2携带者患TNBC的风险是非携带者的5.560倍。BRCA1/2携带者与BC激素受体阴性、肿瘤分级和BC诊断年龄之间存在明显关系。
{"title":"The relationship between mutation carriage of BRCA1/2 and clinicopathological characteristics in women with breast cancer - experience from a diagnostic centre in Turkey.","authors":"Neslihan Duzkale, Onur Can Guler, Suat Kutun, Canan Emiroglu, Serdar Saridemir, Aysun Gokce, Olcay Kandemir, Tugba Taskın Turkmenoglu, Serap Yorubulut, Bahadır Kulah","doi":"10.5114/pjp.2024.142750","DOIUrl":"https://doi.org/10.5114/pjp.2024.142750","url":null,"abstract":"<p><p>The 5-10% of breast cancers (BC) are hereditary, and BRCA1/2 are causative in 25% of those inherited. It was aimed to examine the BRCA1/2 genotype-BC phenotype relationship. In 170 female patients with BC, BRCA1/2 genes were investigated using Next Generation Sequencing. Demographic and clinicopathological characteristics of the patients and correlations of pedigree analysis with BRCA1/2 mutation status were analysed. BRCA1/2 carriage was found to be 9.4%. When the patients were grouped as ≤ 40 and > 40 according to the age at diagnosis of BC, the tumour grade was higher in the ≤ 40 groups. In the study, BRCA1/2 carriage and tumour grade were higher in patients with triple-negative breast cancers (TNBC). The risk of TNBC was 5.560 times higher in BRCA1/2 carriers than in non-carriers. There is a significant relationship between BRCA1/2 carrier and BC hormone receptor negativity, tumour grade, and BC diagnosis age.</p>","PeriodicalId":49692,"journal":{"name":"Polish Journal of Pathology","volume":"75 3","pages":"192-204"},"PeriodicalIF":0.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142511751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pediatric low-grade glioma (PLGG) is a heterogeneous group of primary central nervous system malignancies which represent the most frequent brain tumors in children. Although diagnosis and treatment of PLGG have been improved recently, the molecular mechanisms underlying the oncogenesis and progression of PLGG remain elusive. Studies have revealed critical roles of long non-coding RNAs (lncRNAs) in brain tumor progressions. Here, we aimed to investigate the clinical roles and molecular mechanisms of lncRNA PVT1 in PLGG. Expression of PVT1 was significantly upregulated in PLGG tissues compared with normal brain tissues. Blocking PVT1 effectively suppressed the glucose metabolism of PLGG-derived cells. MicroRNA-187-3p was detected to be remarkedly downregulated in PLGG tissues. Moreover, miR-187-3p is negatively correlated with PVT1 in PLGG tissues. We identified PVT1 sponged miR-187-3p to block its expression in PLGG cells. This association was further verified by RNA pull-down and luciferase assay. Subsequently, rescue experiments validated that inhibition of miR-187-3p in PVT1-silenced PLGG cells successfully overcame the low-PVT1-induced miR-187-3p upregulation and glucose metabolism. In summary, this study reports critical roles and molecular mechanisms of the lncRNA PVT1-accelarated glucose metabolism of PLGG cells.
{"title":"LncRNA-PVT1 enhances glucose metabolism of pediatric low-grade glioma cells through sponging miR-187-3p.","authors":"Beibei Li, Zijian Feng, Yanyan Zheng","doi":"10.5114/pjp.2024.146455","DOIUrl":"https://doi.org/10.5114/pjp.2024.146455","url":null,"abstract":"<p><p>Pediatric low-grade glioma (PLGG) is a heterogeneous group of primary central nervous system malignancies which represent the most frequent brain tumors in children. Although diagnosis and treatment of PLGG have been improved recently, the molecular mechanisms underlying the oncogenesis and progression of PLGG remain elusive. Studies have revealed critical roles of long non-coding RNAs (lncRNAs) in brain tumor progressions. Here, we aimed to investigate the clinical roles and molecular mechanisms of lncRNA PVT1 in PLGG. Expression of PVT1 was significantly upregulated in PLGG tissues compared with normal brain tissues. Blocking PVT1 effectively suppressed the glucose metabolism of PLGG-derived cells. MicroRNA-187-3p was detected to be remarkedly downregulated in PLGG tissues. Moreover, miR-187-3p is negatively correlated with PVT1 in PLGG tissues. We identified PVT1 sponged miR-187-3p to block its expression in PLGG cells. This association was further verified by RNA pull-down and luciferase assay. Subsequently, rescue experiments validated that inhibition of miR-187-3p in PVT1-silenced PLGG cells successfully overcame the low-PVT1-induced miR-187-3p upregulation and glucose metabolism. In summary, this study reports critical roles and molecular mechanisms of the lncRNA PVT1-accelarated glucose metabolism of PLGG cells.</p>","PeriodicalId":49692,"journal":{"name":"Polish Journal of Pathology","volume":"75 4","pages":"324-332"},"PeriodicalIF":0.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143030228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Multinucleate cell angiohistiocytoma (MCAH) is a rare benign cutaneous entity. It classically presents as slowly progressive erythematous to violaceous papules on the distal extremities of middle-aged or elderly women. The entity may clinically resemble granuloma annulare, lichen planus, and several cutaneous vascular proliferations. Histologically, MCAH is characterized by vascular proliferation within the upper and mid-dermis, a mild perivascular inflammatory infiltrate, and charac-teristic bizarre-shaped multinucleate cells. To date, less than 200 cases have been reported in the literature. We present five of the best examples diagnosed in our department to further elucidate this peculiar entity for pathological recognition.
{"title":"Multinucleate cell angiohistiocytoma: a case series and literature review.","authors":"Carolyn Szwed, Malgorzata Maj, Lidia Rudnicka, Joanna Czuwara","doi":"10.5114/pjp.2024.145703","DOIUrl":"https://doi.org/10.5114/pjp.2024.145703","url":null,"abstract":"<p><p>Multinucleate cell angiohistiocytoma (MCAH) is a rare benign cutaneous entity. It classically presents as slowly progressive erythematous to violaceous papules on the distal extremities of middle-aged or elderly women. The entity may clinically resemble granuloma annulare, lichen planus, and several cutaneous vascular proliferations. Histologically, MCAH is characterized by vascular proliferation within the upper and mid-dermis, a mild perivascular inflammatory infiltrate, and charac-teristic bizarre-shaped multinucleate cells. To date, less than 200 cases have been reported in the literature. We present five of the best examples diagnosed in our department to further elucidate this peculiar entity for pathological recognition.</p>","PeriodicalId":49692,"journal":{"name":"Polish Journal of Pathology","volume":"75 4","pages":"261-267"},"PeriodicalIF":0.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143030230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}